Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 200mg	200mg	Injectable powder for solution	15,866,637 L.L
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 1,000mg	1,000mg	Injectable powder for solution	5,411,706 L.L
L01BC06	DIROGIT	G	Capecitabine - 500mg	500mg	Tablet, film coated	11,330,804 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	82,405,803 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	82,405,803 L.L
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	80mg/2ml	Injectable concentrated solution+diluent	16,777,239 L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 80mg/8ml	80mg/8ml	Injectable solution	19,518,281 L.L
L01CD02	DOCETAXEL ACCORD	G	Docetaxel - 80mg/4ml	80mg/4ml	Injectable concentrate for solution	15,099,641 L.L
L01CD02	DOCETAXEL SPC	G	Docetaxel - 80mg/4ml	80mg/4ml	Injectable concentrate for solution	16,906,027 L.L
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	20mg/0.5ml	Injectable concentrated solution+diluent	4,567,721 L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 20mg/2ml	20mg/2ml	Injectable solution	5,313,553 L.L
L01CD02	DOCETAXEL ACCORD	G	Docetaxel - 20mg/ml	20mg/1ml	Injectable concentrate for solution	4,110,814 L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 10mg/5ml	10mg/5ml	Injectable concentrated solution	428,686 L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 2mg/ml	50mg/25ml	Injectable concentrated solution	1,804,780 L.L
L01DB01	DOXO-CELL	G	Doxorubicin HCl - 50mg/25ml	50mg/25ml	Injectable solution	1,794,030 L.L
L01DB01	DOXORUBICINA TEDEC	G	Doxorubicin HCl - 50mg/25ml	50mg/25ml	Injectable concentrate for solution	2,015,764 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 70mg	70mg	Tablet, film coated	219,542,925 L.L
L01EA02	DALEUBIN	G	Dasatinib - 70mg	70mg	Tablet, film coated	93,260,179 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 50mg	50mg	Tablet, film coated	219,541,889 L.L
L01EA02	DALEUBIN	G	Dasatinib - 50mg	50mg	Tablet, film coated	92,470,390 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 20mg	20mg	Tablet, film coated	105,380,480 L.L
L01EA02	DALEUBIN	G	Dasatinib - 20mg	20mg	Tablet, film coated	75,022,315 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 140mg	140mg	Tablet, film coated	486,544,291 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 140mg	140mg	Tablet, film coated	256,075,943 L.L
L01EL01	DULLARMA	G	Ibrutinib - 140mg	140mg	Capsule, hard	422,860,803 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	156,171,284 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	468,512,749 L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L

...